DSIP / BPC-157 / CJC

Delta-sleep-inducing peptide (DSIP) is a neuropeptide with diverse effects on endocrine and physiological processes in the central nervous system. First isolated in 1977 from the brains of rats during slow-wave sleep, DSIP has gained attention for its multifaceted roles. Named for its ability to induce sleep in rabbits, DSIP is not only associated with sleep patterns but also has broader implications.

Body Protection Compound-157 (BPC-157) is a penta-decapeptide composed of 15 amino acids and is derived from the larger body protection compound (BPC) found in human gastric juice. Extensive animal studies have demonstrated its remarkable ability to accelerate the healing of diverse wounds, including those affecting muscles, tendons, and ligaments.

CJC-1295 (No DAC) is a synthetic derivative of growth hormone-releasing hormone (GHRH) designed to promote sustained growth hormone release from the pituitary gland. Unlike other peptides, CJC-1295 (No DAC) does not include the Drug Affinity Complex (DAC), resulting in a shorter half-life but allowing for more precise control of growth hormone levels.